Novo Holdings A/S - 28 Oct 2025 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S
Issuer symbol
MPLT
Transactions as of
28 Oct 2025
Net transactions value
+$16,199,997
Form type
4
Filing time
30 Oct 2025, 16:31:43 UTC
Previous filing
27 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Novo Holdings A/S 10%+ Owner TUBORG HAVNEVEJ 19, HELLERUP, DENMARK /s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S 30 Oct 2025 0001388325

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MPLT Voting Common Stock Conversion of derivative security +2,733,681 2,733,681 28 Oct 2025 Direct F1
transaction MPLT Voting Common Stock Purchase $16,199,997 +952,941 +35% $17.00 3,686,622 28 Oct 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MPLT Series C Preferred Stock Conversion of derivative security $0 -26,191,207 -100% $0.000000 0 28 Oct 2025 Voting Common Stock 1,558,999 Direct F1
transaction MPLT Series D Preferred Stock Conversion of derivative security $0 -19,734,671 -100% $0.000000 0 28 Oct 2025 Voting Common Stock 1,174,682 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
F2 Represents a purchase from the underwriters in the Issuer's initial public offering.